Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07693270 · ClinicalTrials.gov registry record

Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery

A clinical trial, sponsored by University of California, San Diego.

Not yet
Registry status
100
Enrollment target

NCT07693270: Clinical Trial study, sponsored by University of California, San Diego.

NCT07693270 is a clinical trial that has not yet begun recruiting, run by University of California, San Diego. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07693270 has not yet begun recruiting, sponsored by University of California, San Diego.

NOT YET RECRUITING
Registry status
100 participants
Enrollment target

Study Summary

The mechanisms leading to opioid tolerance or dependence are not well understood and there are currently no biomarkers for predicting who is at risk for development of OUD. The purpose of this project is to support the feasibility of detecting a miRNA bio-behavioral signature of opioid misuse risk that will demonstrate improved predictive precision compared to current tools such as polygenic risk scores (PRS). Specifically, the study will address key goals of the Wellcome Leap program to develop scalable measures assessing individual addiction susceptibility and quantifying addiction risk and progression during prescription drug use. The study will utilize behavioral, genomics, and bioinformatics pipelines to characterize opioid-induced miRNA expression dynamics among trauma and surgical patients prescribed opioids at discharge. Based on results from this study, the research will develop a high-throughput screening assay to predict risk for opioid use disorder (OUD). The hypothesis is that miRNAs will serve as powerful bio-signatures for predicting long-term clinical outcomes in patients treated with opioids for pain management following trauma injury and/or surgery.

Primary Outcome

We will collect blood from participants (about 15mL total) for DNA, miRNA, and mRNA sequencing. The blood draw for miRNA and mRNA sequencing, DNA genotyping, and bioinformatics analysis will be conducted at baseline and at subsequent in-person time points. All biospecimens will be sequenced and analyzed at UCSD's Center for Computational Biology and Bioinformatics. We will also collect baseline demographic, clinical and social data (including social determinants of health questionnaire, electron

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-07
Est. Completion 2027-06
University of California, San Diego

775 total trials

What is known before NCT07693270 opens enrollment

NCT07693270 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT07693270 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07693270 about?

NCT07693270 is a clinical study titled "Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery". The mechanisms leading to opioid tolerance or dependence are not well understood and there are currently no biomarkers for predicting who is at risk for development of OUD. The purpose of this project is to support the feasibility of detecting a miRNA bio-behavioral signature of opioid misuse risk t...

What is the current status of trial NCT07693270?

This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-07. Estimated completion is 2027-06.

Who is sponsoring clinical trial NCT07693270?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07693270, the US trial registry maintained by the National Library of Medicine. NCT07693270 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.